3 days popular7 days popular1 month popular3 months popular

Common side effect of radiation treatment for prostate cancer

Factoring in anatomy and the radiation therapy dose can help doctors predict a prostate cancer patient’s risk of suffering from rectal bleeding as a side effect of therapy, and tailor treatment to prevent the problem, suggests a large study being presented at the 57th Annual Meeting of the American Association of Physicists in Medicine (AAPM). [...]

Study: STAT3 inhibitor galiellalactone reduces tumor growth and metastatic spread in an animal model of prostate cancer

Members of Glactone Pharma’s innovator group have published an article in the highly rated scientific journal European Urology demonstrating that the STAT3 inhibitor galiellalactone (GPA500) reduces both the growth of primary prostate tumors and the metastatic spread in a model of advanced prostate cancer. This is the first study showing that the STAT3 inhibitor has [...]

Turning up the volume on prostate cancer: RIT research on targeted molecular imaging could improve detection and treatment

A targeted molecular-imaging method under development at Rochester Institute of Technology could help detect early stages of prostate cancer and improve image-directed biopsies. RIT professor Hans Schmitthenner is designing molecular imaging compounds that will selectively target prostate cancer cells and light them up with contrast dyes. A $444,367 grant from the National Institutes of Health [...]

Tests to gauge genetic risks for prostate cancer now are feasible

UCSF-Kaiser Permanente study shows potential for diagnostic blood test Men with an elevated, genetically inherited risk for prostate cancer could be routinely identified with a simple blood or urine test, scientists at UC San Francisco and Kaiser Permanente Northern California have concluded, potentially paving the way to better or earlier diagnosis. The study, which compared [...]

Molecular MRI aims at component of multiple cancers

Novel MRI agents successfully target tumor-specific physiology A relatively new biomarker called prostate-specific membrane antigen (PSMA) is the bullseye for three new magnetic resonance imaging (MRI) agents that bind to the protein in not only prostate cancer, but a range of tumor types, according to research unveiled at the 2015 annual meeting of the Society [...]